XFDA, INC: public contracts won without a rival in United States: 3 uncontested awards; 100% of its awards; 3 without a competition; 0 single bid.
Assay record ASY-US-18DXT6D0IW · Cite as: Assay Systems, “XFDA, INC: public contracts won without a rival in United States”, https://assay-systems.com/register/us/uncontested/s/xfda-inc/
XFDA, INC won 3 of its 3 public contract awards in United States without a rival from 2023-10-16 to 2024-12-05, worth $-43,926: 3 without a competition and 0 after a competition that drew a single bid. 1 buyer awarded it without a rival, the largest Securities and Exchange Commission with 3.
An award is uncontested when the buyer had no rival offer to weigh: it was made without a competition (direct award, negotiated procedure without a call for tenders, sole-source or advance-notice contract), or a competition was held and only one bid arrived. Every count below is built award by award from the official notices. Awards to individuals are not included.
Securities and Exchange Commission gave XFDA, INC 3 awards: 3 without a competition, 0 after a competition with a single bid. First 2023-10-16, latest 2024-12-05.
| Date | Buyer | How | Value | Stated reason |
|---|---|---|---|---|
| 2024-12-05 | Securities and Exchange Commission 50310222C0055 | No competition NOT COMPETED | $-46,326 | MOBILIZATION, ESSENTIAL R&D (FAR 6.302-3) |
| 2024-03-08 | Securities and Exchange Commission 50310224C0029 | No competition NOT COMPETED | $22.3K | MOBILIZATION, ESSENTIAL R&D (FAR 6.302-3) |
| 2023-10-16 | Securities and Exchange Commission 50310222C0081 | No competition NOT COMPETED | $-19,875 | MOBILIZATION, ESSENTIAL R&D (FAR 6.302-3) |
Every uncontested award in United States · All countries
Source: USAspending.gov prime award transactions (contracts). Awards are matched to their buyer and supplier as published. Updated 17 October 2026.